Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Women may need different blood pressure guidelines than men for heart disease prevention.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.